Equity Analysis /
Australia

AU : Paradigm Biopharmaceuticals - Major inflection point ahead

    Iain Wilkie
    Iain Wilkie

    Analyst - Healthcare & Biotechnology

    CGS-CIMB
    28 October 2021
    Published by